many AI tools do not cover the five levels of AMP discovery and design [
what are these levels? basic screening to clinical trials?
many AI tools do not cover the five levels of AMP discovery and design [
what are these levels? basic screening to clinical trials?
there is protein synthesis,phospholipases, capsular polysaccharides, lipopolysaccharides, membrane and QS pro-teins, metal absorption, cytokines and biofilms [ 152 ,156 ].
not as familiar w/ these AB virulence factors
ackbone sampling, side-chainoptimization and energy-based refinement
more details on these methods?
nonlinear interactions between features
'nonlinear interactions' is thrown around often; just a behavior that causes exponential or multi-faceted consequences?
ecision trees trained on bootstrapped subsets of the data
maybe familiar? random forests use decision trees -> like a flow chart?
k-mer frequencies, dipeptideand tripeptide motifs, pseudo-amino acid composition
are these all bad for AMP effectiveness?
Featureextraction,
vaguely familiar; just looking for specific qualities? generating specific qualities?
de novo peptide design and multi-objective optimization, integrating activity, selectivityand stability considerations into the design process
not very familiar with these; have heard of de novo peptide design and selectivity/stability considerations